Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities.
Piramal Pharma Limited (PPLPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The PPLPHARMA share price is ₹246.20 (+3.34% today), with a market capitalisation of ₹326B. MarketRipple tracks the PPLPHARMA investment thesis, the ripple-chain impact of market events on Piramal Pharma Limited, and the Healthcare sector outlook.
Open
₹239.50
High
₹247.44
Low
₹239.50
Prev. Close
₹238.25
52W High
₹247.44
52W Low
₹132.30
Day range
₹239.50–₹247.44
52-week range
₹132.30–₹247.44
Volume
2.2M
P/E
—
ROE
-2.6%
D/E
0.70
Margin
-2.1%
Piramal Pharma Limited (NSE: PPLPHARMA) is currently trading at ₹246.20 (+3.34%).
Piramal Pharma Limited's market capitalization is ₹326B.
Piramal Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Piramal Pharma Limited currently reads strongly positive, based on 11 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.